Clinical management of metastatic colorectal cancer in the era of precision medicine - Ciardiello - 2022 - CA: A Cancer Journal for Clinicians - Wiley Online Library
Identification of actionable alterations in colorectal cancer are leading to the development of novel treatment strategies - Mayo Clinic
Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study - The Lancet Oncology
The Role of the Epidermal Growth Factor Receptor in the Mechanism and Treatment of Colorectal Cancer - Nirit Yarom - Discovery Medicine
Biomarkers in Targeted Therapy for Colorectal Cancer
Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies | Journal of Molecular Medicine
Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies | Journal of Molecular Medicine
Targeting EGFR pathway in metastatic colorectal cancer- tumour heterogeniety and convergent evolution - ScienceDirect
Epidermal growth factor receptor (EGFR)-related signaling pathway in... | Download Scientific Diagram
EGFR | Cancer Genetics Web
APMG Colon Molecular Pathways
Targeted Drug Trio for Colorectal Cancer with BRAF Mutations - NCI
New combination therapy offers bowel cancer patients extra treatment option
RESISTANCE TO ANTI-EGFR THERAPIES IN COLORECTAL CANCER – Sanguine Bio Researcher Blog
IJMS | Free Full-Text | Recent Advances in Targeting the EGFR Signaling Pathway for the Treatment of Metastatic Colorectal Cancer
Frontiers | The Role of Anti-EGFR Monoclonal Antibody in mCRC Maintenance Therapy
Biomarqueurs des cancers colorectaux utiles en pratique clinique – FMC-HGE
Molecular Markers for the Prediction of Anti-EGFR Monoclonal Antibody Treatment Efficacy in Metastatic Colorectal Cancer
Beyond KRAS status and response to anti-EGFR therapy in metastatic colorectal cancer | Pharmacogenomics
Feedback activation of EGFR/wild-type RAS signaling axis limits KRASG12D inhibitor efficacy in KRASG12D-mutated colorectal cancer | Oncogene
Mechanisms of resistance to anti-EGFR therapy in colorectal cancer. - Abstract - Europe PMC
Comprehensive review of targeted therapy for colorectal cancer | Signal Transduction and Targeted Therapy
Biomarkers in colorectal cancer: Current clinical utility and future perspectives
Precision medicine for metastatic colorectal cancer in clinical practice - Julian E. Riedesser, Matthias P. Ebert, Johannes Betge, 2022
Toward an individualizing therapy for colorectal cancer: the example of the anti-EGFR monoclonal antibodies | Personalized Medicine
![PDF] Mechanisms of resistance to anti-EGFR therapy in colorectal cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2e5f89dec8a25afc1d61dc3d7197afa33839845d/3-Figure2-1.png "PDF] Mechanisms of resistance to anti-EGFR therapy in colorectal cancer | Semantic Scholar")